Rule Health and Human Services DepartmentFood and Drug Administration June 22, 2026

Medical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Samples

The Food and Drug Administration (FDA) is classifying the simple in vitro diagnostic device for the detection of secreted proteins from Bacillus species (spp.) in human clinical samples into class II...

Want the full context? Use Regulator to track the source, deadlines, and weekly briefing.
Document type: Rule. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-06-22.

Why this matters to food and beverage teams

This rule is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.

Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.

View original source document

Turn this source item into a compliance workflow

Get weekly F&B regulatory briefings, deadline tracking, and beta access to the searchable Regulator workspace.